Numaferm Revenue and Competitors

Düsseldorf, DEU

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Numaferm's estimated annual revenue is currently $2M per year.(i)
  • Numaferm's estimated revenue per employee is $98,000

Employee Data

  • Numaferm has 20 Employees.(i)
  • Numaferm grew their employee count by -17% last year.

Numaferm's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
CEOReveal Email/Phone
3
Chief Operating OfficerReveal Email/Phone
4
Scientist Downstream Processing & AnalyticsReveal Email/Phone
5
Associate ScientistReveal Email/Phone
6
Senior Scientist Downstream Processing & AnalyticsReveal Email/Phone
7
Senior ScientistReveal Email/Phone
8
BTA Downstream Processing & AnalyticsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.2M14-26%N/AN/A
#2
$22.2M14418%N/AN/A
#3
$2.5M2637%N/AN/A
#4
$69.1M39512%N/AN/A
#5
$5.2M460%N/AN/A
#6
$15.1M1088%N/AN/A
#7
$21.2M141-20%$70MN/A
#8
$2.7M288%N/AN/A
#9
$1M129%N/AN/A
#10
$13.7M9846%N/AN/A
Add Company

What Is Numaferm?

We believe that in the near future peptides have found their way into new markets and are a well-known feed stock for better products in life sciences and beyond. NUMAFERM supports you in these developments – from discovery to commercial production.

keywords:N/A

N/A

Total Funding

20

Number of Employees

$2M

Revenue (est)

-17%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Numaferm News

2022-04-06 - The peptide therapeutics contract API manufacturing market is ...

... Philipp Burling (Chief Financial Officer, NUMAFERM). The research includes detailed profiles of key service providers (listed below)...

2022-03-22 - Peptide Therapeutics: Contract API Manufacturing Market ...

... NSJ Prayog Life Sciences; NUMAFERM; ONL Therapeutics; OPKO Health; Oramed Pharmaceuticals; ORPEGEN Peptide Chemicals; Oryn Therapeutics...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.7M2117%N/A
#2
$2.1M210%N/A
#3
$2M220%N/A
#4
$2.5M28-30%N/A
#5
$4.8M3135%N/A